Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          
Bio B2BJHL Biotech, Inc. 〉JHL1178 Ramucirumab Biosimilar

JHL1178 Ramucirumab Biosimilar

JHL1178 Ramucirumab Biosimilar

Human IgG1 that binds to VEGFR2

Request for Collaboration
Overview
JHL1178 is a proposed biosimilar to ramucirumab, a human IgG1 that binds to VEGFR2, which in turn blocks the natural ligands secreted by tumors, therefore can inhibit tumor angiogenesis.
Application
NSCLC, GC,CRC
People who like this also like
  • Cancer screening by next generation sequencingCancer screening by next generation sequencing
  • Decellularization matrixDecellularization matrix
  • cGMP Complied Pilot FacilitycGMP Complied Pilot Facility
  • Cell selection adhesion technologyCell selection adhesion technology
  • Good Agriculture Practice Cultivation PlatformGood Agriculture Practice Cultivation Platform
  • CRAM ServicesCRAM Services
  • PHDC-01PHDC-01
  • AmCAD UOAmCAD UO
  • SB05SB05
  • New Project ManagementNew Project Management